MedImmune FluMist Nasal Influenza Vaccine from Canada
FluMist live attenuated influenza vaccine administered intranasally in measured sprayers for retail. As an immunological product, it qualifies for HTS 3002.15.00.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Refrigerated nasal spray; 42-day room temp allowance
• Live virus precautions; no egg allergy contraindication
• Administration device validation for dose accuracy